Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
amantadine viregyt-k
4
viregyt-k extrapyramidal
4
extrapyramidal symptoms
4
symptoms parkinsonian
4
parkinsonian patients
4
amantadine
1
extrapyramidal
1
symptoms
1
parkinsonian
1
patients
1
Similar Publications
[Therapeutic effect of dopaminergic substances in drug-resistant Lennox-Gastaut syndrome].
Cesk Neurol Neurochir
January 1989
The authors administered to 18 children with an expressed pharmaco-resistant Lennox-Gastaut syndrome as adjuvant treatment medium doses of amantadine (Viregyt-K, Egyt), 8 mg/kg/day divided into 1-2 portions or L-DOPA (Nakom, Lek) 22 mg/kg/day in 3-4 portions. The mean age at the time of administration of the agonist or dopamine precursor was 5 years (1-12.5 years).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!